Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients

BACKGROUND: Patients with malignancy are particularly vulnerable to infection with Severe Acute Respiratory Disease‐Coronavirus‐2 (SARS‐CoV‐2) given their immunodeficiency secondary to their underlying disease and cancer‐directed therapy. We report a case series of patients with cancer who received...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Med
Auteurs principaux: Tremblay, Douglas, Seah, Carina, Schneider, Thomas, Bhalla, Sheena, Feld, Jonathan, Naymagon, Leonard, Wang, Bo, Patel, Vaibhav, Jun, Tomi, Jandl, Thomas, Rahman, Farah, Liu, Sean T. H., Aberg, Judith A., Bouvier, Nicole
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Cancer Biology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537286/
https://ncbi.nlm.nih.gov/pubmed/32945149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3457
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires